We have had a great pleasure to participate in the 14th National Congress of the Austrian Society of Nuclear Medicine and Molecular Imaging (OGNMB) held on January 19-21 in Bad Ischl known as “the heart of the Salzkammergut”.
POLATOM’s presentation of its research and development of PSMA-Peptides for Theranostics aroused great interest among nuclear medicine specialists. We are looking forward to expand our portfolio of medicinal products for radiolabelling to further improve cancer detection and treatment.
Stay tuned for more…
#POLATOM #theranostics #nuclearmedicine #radiopharmaceuticals #OGNMB #PSMA